𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression and regulatory role of receptors for vasoactive intestinal peptide in bone cells

✍ Scribed by Pernilla Lundberg; Ulf H. Lerner


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
66 KB
Volume
58
Category
Article
ISSN
1059-910X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

An intense network of nerve fibers can be demonstrated in skeletal tissues, not only in the periosteum but also within cortical bone, growth plate, and bone marrow. This neuro‐osteogenic network expresses a restricted number of signalling molecules, including neuropeptides, neurotransmitters, and neurotrophins. Several lines of evidence indicate that receptors for these molecules are present on bone cells and that activation of these receptors leads to changes in bone cell activities. In addition, deletion of signalling molecules has been shown to alter bone metabolism. In the present review, these studies are summarized with a focus on distribution and effects of vasoactive intestinal peptide. Microsc. Res. Tech. 58:98–103, 2002. © 2002 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Differential expression of vasoactive in
✍ Yasmina Juarranz; Irene Gutiérrez-Cañas; Begoña Santiago; Mar Carrión; José L. P 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB 👁 2 views

## Abstract ## Objective Vasoactive intestinal peptide (VIP) has shown potent antiinflammatory effects in murine arthritis and ex vivo in human rheumatoid arthritis (RA) synovial cells. To investigate the potential endogenous participation of this system in the pathogenesis of RA, we analyzed the

Type 1 vasoactive intestinal peptide rec
✍ Gkonos, Peter J.; Guo, Fang; Burnstein, Kerry L. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 766 KB

BACKGROUND. Type 1 vasoactive intestinal peptide receptor (VIP1R) is expressed in many secretory epithelial cells. We investigated VIP1R expression as a marker of prostate secretory epithelial differentiation in normal and malignant prostate tissues and in PC-3 human prostate cancer cells either lac